세계의 의료용 외골격 시장 : 산업 동향 및 세계 예측(-2035년) - 대상 부위별, 작동 모드별, 외골격 형태별, 이동성별, 최종사용자별, 주요 지역별 분석

Medical Exoskeleton Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Body Part Covered (Upper Body, Lower Body and Full Body), Mode of Operation (Powered, Passive and Hybrid), Form of Exoskeleton (Rigid and Soft), Mobility (Fixed / Supported and Mobile), End Users (Patients and Healthcare Providers), and Key Geographical Regions (North America, Europe, Asia-Pacific, and Rest of the World)

The Medical Exoskeleton Market is valued at USD 1.90 billion in 2024 growing at a CAGR of 20.8% during the forecast period 2024-2035.

Medical exoskeletons, wearable robotic devices tailored to aid individuals with mobility impairments, harness a blend of mechanical, electronic, and computer-controlled systems to bolster and refine the user's movement. Typically, homing in on specific body parts affected by injury or disability, these devices diverge from conventional assistive tools like wheelchairs and crutches. Certain iterations of powered exoskeleton technology furnish active mobility assistance by amplifying the user's strength and stamina through the integration of actuators and sensors. The potential of medical exoskeletons is vast, resonating with a considerable patient demographic in dire need of mobility support. Neurological disorders, in particular, pose a formidable public health challenge, impacting over one billion individuals worldwide. Traumatic brain injury (TBI), as highlighted by the Lancet Neurology Commission, stands as a pervasive global concern afflicting 55 million people, while current estimates suggest a populace of 20.6 million grappling with spinal cord injury.

Despite the substantial population contending with mobility impairments, the exoskeleton market maintains a relatively niche status, albeit gradually garnering attention. This can be attributed to various factors, including the elevated costs associated with exoskeleton technology and a prevalent lack of awareness among both patients and healthcare providers. Nonetheless, with ongoing technological strides and heightened awareness, the medical exoskeleton market stands poised for expansion, offering the promise of enhanced accessibility and quality of life for those in need of mobility assistance. Indeed, several companies are spearheading the development of exoskeleton technology fused with advanced features such as controllers and software applications, empowering users and clinicians alike to establish goals, fine-tune assistance levels, and scrutinize movement patterns tailored to personalized rehabilitation plans.

Key Market Segments

Body Part Covered

• Upper Extremity
• Lower Extremity
• Full Body

Mode of Operation

• Powered
• Passive
• Hybrid

Form

• Rigid
• Soft

Mobility

• Fixed / Supported
• Mobile

End Users

• Patients
• Healthcare Providers

Geography

• North America
• Europe
• Asia-Pacific
• Rest of the World

Research Coverage:

• An insightful overview of exoskeleton industry, highlighting details on origin of exoskeletons. This chapter provides information on classification of exoskeleton, along with applications, features and limitations associated with exoskeleton. Further, it concludes with a discussion on future perspectives in this domain.
• This overview provides insight into the current market landscape of medical exoskeletons, considering various parameters such as development status (commercialized and under development), body part coverage (upper extremity, lower extremity, and full body), mode of operation (powered, passive, and hybrid), exoskeleton form (rigid and soft exosuit), mobility (stationary and mobile), user-machine interface (including app-based, handheld controller, on-device buttons/control panels, and brain control), and advanced features (such as data capture, gamification, and customized assistance). Additionally, it addresses end users (patients, medical professionals, and researchers), patient age groups (pediatric to adolescent, adolescent to elderly), and exoskeleton settings (home/community and rehabilitation centers). It also touches on breakthrough device designations, exoskeleton technology/software, maximum weight, weight carrying capacity, and dimensions. Furthermore, it lists companies involved in medical exoskeleton development/commercialization, providing details on establishment year, company size, headquarters location, ownership, and additional services. Lastly, it highlights the most active companies in terms of medical exoskeleton offerings.
• A comprehensive analysis of product competitiveness within the medical exoskeleton market, focusing on supplier strength (including years of experience, company size, and exoskeleton portfolio), product competitiveness (encompassing device mobility, exoskeleton form, operation mode, advanced features, user-machine interface, additional services, breakthrough designation, and development status), and target end users.
• Comprehensive profiles of prominent medical exoskeleton companies selected based on the quantity and application scope of wearable exoskeletons in their product lineup. Each profile provides a succinct overview of the company, including establishment year, employee count, headquarters location, and leadership team details, along with insights into financial performance where applicable. Additionally, the profiles encompass information on the company's product range, recent advancements, and an informed perspective on future prospects.
• Tabulated summaries of leading medical exoskeleton companies selected based on the quantity and application range of wearable exoskeletons in their product offerings. Each tabulated profile provides an overview of the company, detailing establishment year, employee count, headquarters location, and key leadership team members. Additionally, the profiles include information on the company's product portfolio.
• A comprehensive analysis of the medical exoskeleton market's recent partnerships and collaborations established since 2017. This analysis considers various parameters, including the year of partnership, partnership type (such as mergers and acquisitions, product development and commercialization agreements, licensing agreements, service agreements, product development and manufacturing agreements, joint ventures, manufacturing and supply agreements, and product distribution agreements), partner type (industry and non-industry), business globalization trends, and the most active players. Additionally, it provides insights into the regional distribution of the companies engaged in these agreements.
• A thorough examination of patents filed or granted for exoskeletons since 2016, encompassing diverse relevant factors such as patent type, application and publication years, geographical origins, applicant types, publication timelines, top CPC symbols, and key players in terms of the quantity of patents filed or granted. Additionally, it includes an in-depth patent benchmarking analysis.
• An exhaustive examination of the present and prospective market through the lens of the Blue Ocean Strategy, providing a strategic roadmap for nascent medical exoskeleton enterprises to tap into uncontested market spaces. This guide encompasses thirteen strategic tools aimed at facilitating a transition towards a Blue Ocean strategy, enabling companies to secure a competitive advantage in the market.
• A comprehensive examination of the factors influencing the expansion of the medical exoskeleton market. This analysis includes the identification and evaluation of significant drivers, potential limitations, emerging prospects, and current obstacles.

Key Benefits of Buying this Report

• The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
• Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
• The report provides stakeholders with a pulse on the Medical Exoskeleton Market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.

Leading Market Companies

• Bionic Yantra

CYBERDYNE

• Ekso Bionics
• ExoAtlet
• Fourier Intelligence
• Gloreha
• Guangzhou Yikang Medical Equipment
• Hexar Humancare
• Hocoma
• MediTouch
• Milebot Robotics
• Myomo
• Neofect
• NextStep Robotics
• Panasonic
• ReWalk Robotics
• Rex Bionics
• Roam Robotics
• Trexo Robotics
• Tyromotion
• U&O Technologies

TABLE OF CONTENTS

Table Of Contents

1. PREFACE

• 1.1. Introduction
• 1.2. Key Market Insights
• 1.3. Scope of the Report
• 1.4. Research Methodology
• 1.5. Frequently Asked Questions
• 1.6. Chapter Outlines

2. RESEARCH METHODOLOGY

• 2.1. Chapter Overview
• 2.2. Research Assumptions
• 2.3. Project Methodology
• 2.4. Forecast Methodology
• 2.5. Robust Quality Control
• 2.6. Key Market Segmentations
• 2.7. Key Considerations
  • 2.7.1. Demographics
  • 2.7.2. Economic Factors
  • 2.7.3. Government Regulations
  • 2.7.4. Supply Chain
  • 2.7.5. COVID Impact / Related Factors
  • 2.7.6. Market Access
  • 2.7.7. Healthcare Policies
  • 2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

• 3.1. Chapter Overview
• 3.2. Market Dynamics
  • 3.2.1. Time Period
    • 3.2.1.1. Historical Trends
    • 3.2.1.2. Current and Forecasted Estimates
  • 3.2.2. Currency Coverage
    • 3.2.2.1. Overview of Major Currencies Affecting the Market
    • 3.2.2.2. Impact of Currency Fluctuations on the Industry
  • 3.2.3. Foreign Exchange Impact
    • 3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
    • 3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
  • 3.2.4. Recession
    • 3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
    • 3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
  • 3.2.5. Inflation
    • 3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
    • 3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY

5. INTRODUCTION

• 5.1. Chapter Overview
• 5.2. Overview of Exoskeleton
• 5.3. History of Exoskeleton
• 5.4. Classification of Exoskeleton
  • 5.4.1. Based on Body Part Supported
  • 5.4.2. Based on Form of Exoskeleton
  • 5.4.3. Based on Mode of Operation
  • 5.4.4 Based on Mobility
• 5.5. Applications of Exoskeleton
• 5.6. Features of Exoskeleton
• 5.7. Limitations of Exoskeleton
• 5.8. Future Perspectives

6. MEDICAL EXOSKELETON: MARKET LANDSCAPE

• 6.1. Chapter Overview
• 6.2. Medical Exoskeleton: Overall Market Landscape
  • 6.2.1. Analysis by Status of Development
  • 6.2.2. Analysis by Type of Body Part Covered
  • 6.2.3. Analysis by Mode of Operation
  • 6.2.4. Analysis by Type of Body Part Covered and Mode of Operation
  • 6.2.5. Analysis by Form of Exoskeleton
  • 6.2.6. Analysis by Mode of Operation and Form of Exoskeleton
  • 6.2.7. Analysis by Type of Body Part Covered and Form of Exoskeleton
  • 6.2.8. Analysis by Device Mobility
  • 6.2.9. Analysis by Mode of Operation and Device Mobility
  • 6.2.10. Analysis by Form of Exoskeleton and Device Mobility
  • 6.2.11. Analysis by Type of Body Part Covered and Device Mobility
  • 6.2.12. Analysis by User-Machine Interface
  • 6.2.13. Analysis by Type of Body Part Covered and User-Machine Interface
  • 6.2.14. Analysis by Mode of Operation and User-Machine Interface
  • 6.2.15. Analysis by Availability of Advanced Features
  • 6.2.16. Analysis by End User
  • 6.2.17. Analysis by Patient Age Group
  • 6.2.18. Analysis by Exoskeleton Setting for Patients
  • 6.2.19. Analysis by Breakthrough Designation
• 6.3. Medical Exoskeleton: Developer: Landscape
  • 6.3.1. Analysis by Year of Establishment
  • 6.3.2. Analysis by Company Size
  • 6.3.3. Analysis by Location of Headquarters
  • 6.3.4. Analysis by Company Size and Location of Headquarters
  • 6.3.5. Analysis by Company Ownership
  • 6.3.6. Analysis by Location of Headquarters and Company Ownership
  • 6.3.7. Analysis by Additional Services Offered
  • 6.3.8. Most Active Players: Analysis by Number of Medical Exoskeleton

7. MEDICAL EXOSKELETON: PRODUCT COMPETITIVENESS ANALYSIS

• 7.1 Chapter Overview
• 7.2. Assumptions and Key Parameters
• 7.3. Methodology
• 7.4. Medical Exoskeleton: Product Competitiveness Analysis
  • 7.4.1. Product Competitiveness Analysis: Upper Body Medical Exoskeleton
    • 7.4.1.1. Product Competitiveness Analysis: Upper Body, Powered Exoskeleton
    • 7.4.1.2. Product Competitiveness Analysis: Upper Body, Passive Exoskeleton
    • 7.4.1.3. Product Competitiveness Analysis: Upper Body, Hybrid Exoskeleton
  • 7.4.2. Product Competitiveness Analysis: Lower Body Exoskeleton
    • 7.4.2.1. Product Competitiveness Analysis: Lower Body, Powered Exoskeleton
    • 7.4.2.2. Product Competitiveness Analysis: Lower Body, Passive Exoskeleton
    • 7.4.2.3. Product Competitiveness Analysis: Lower Body, Hybrid Exoskeleton
  • 7.4.3. Product Competitiveness Analysis: Full Body Medical Exoskeleton

8. EXOSKELETON DEVELOPERS: DETAILED COMPANY PROFILES

• 8.1. Chapter Overview
• 8.2. CYBERDYNE
  • 8.2.1. Company Overview
  • 8.2.2. Financial Information
  • 8.2.3. Product Portfolio
  • 8.2.4 Recent Developments and Future Outlook
• 8.3. Ekso Bionics
  • 8.3.1. Company Overview
  • 8.3.2. Financial Information
  • 8.3.3. Product Portfolio
  • 8.3.4 Recent Developments and Future Outlook
• 8.4. ExoAtlet
  • 8.4.1. Company Overview
  • 8.4.2. Product Portfolio
  • 8.4.3. Recent Developments and Future Outlook
• 8.5. Fourier Intelligence
  • 8.5.1. Company Overview
  • 8.5.2. Product Portfolio
  • 8.5.3. Recent Developments and Future Outlook
• 8.6. Gloreha
  • 8.6.1. Company Overview
  • 8.6.2. Product Portfolio
  • 8.6.3. Recent Developments and Future Outlook
• 8.7. Guangzhou Yikang
  • 8.7.1. Company Overview
  • 8.7.2. Product Portfolio
  • 8.7.3. Recent Developments and Future Outlook
• 8.8. Hexar Humancare
  • 8.8.1. Company Overview
  • 8.8.2. Product Portfolio
  • 8.8.3. Recent Developments and Future Outlook
• 8.9. Hocoma
  • 8.9.1. Company Overview
  • 8.9.2. Product Portfolio
  • 8.9.3. Recent Developments and Future Outlook
• 8.10. Panasonic
  • 8.10.1. Company Overview
  • 8.10.2. Financial Information
  • 8.10.3. Product Portfolio
  • 8.10.4. Recent Developments and Future Outlook
• 8.11. Tyromotion
  • 8.11.1. Company Overview
  • 8.11.2. Product Portfolio
  • 8.11.3. Recent Developments and Future Outlook

9. EXOSKELETON DEVELOPERS: TABULATED COMPANY PROFILES

• 9.1. Chapter Overview
• 9.2. Bionic Yantra
• 9.3. MediTouch
• 9.4. Milebot Robotics
• 9.5. Myomo
• 9.6. Neofect
• 9.7. NextStep Robotics
• 9.8. ReWalk Robotics
• 9.9. Rex Bionics
• 9.10. Roam Robotics
• 9.11. Trexo Robotics
• 9.12. U&O Technologies

10. MEDICAL EXOSKELETON: PARTNERSHIPS AND COLLABORATIONS

• 10.1. Chapter Overview
• 10.2. Partnership Models
• 10.3. Medical Exoskeleton: List of Partnerships and Collaborations
  • 10.3.1. Analysis by Year of Partnership
  • 10.3.2. Analysis by Type of Partnership
  • 10.3.3. Analysis by Year and Type of Partnership
  • 10.3.4. Analysis by Type of Partner
  • 10.3.5. Analysis by Year of Partnership and Type of Partner
  • 10.3.6. Analysis by Purpose of Partnership
  • 10.3.7. Analysis by Geography
    • 10.3.7.1. Local and International Agreements
    • 10.3.7.2. Intracontinental and Intercontinental Agreements
    • 10.3.7.3. Most Active Players: Distribution by Number of Partnerships

11. PATENT ANALYSIS

• 11.1. Chapter Overview
• 11.2. Scope and Methodology
• 11.3. Exoskeleton: Patent Analysis
  • 11.3.1. Analysis by Patent Application Year
  • 11.3.2. Analysis by Patent Publication Year
  • 11.3.3. Analysis by Type of Patent and Patent Publication Year
  • 11.3.4. Analysis by Publication Time
  • 11.3.5. Analysis by Patent Jurisdiction
  • 11.3.6. Analysis by CPC symbols
  • 11.3.7. Analysis by Type of Applicant
  • 11.3.8. Leading Players: Analysis by Number of Patents
  • 11.3.9. Leading Patent Assignees: Analysis by Number of Patents
• 11.4. Exoskeleton: Patent Benchmarking
  • 11.4.1. Analysis by Patent Characteristics
  • 11.4.2. Exoskeleton: Patent Valuation
• 11.5. Leading Players by Number of Citations

12. BLUE OCEAN STRATEGY

• 12.1. Overview of Blue Ocean Strategy
  • 12.1.1. Red Oceans
  • 12.1.2. Blue Oceans
  • 12.1.3. Comparison of Red Ocean Strategy and Blue Ocean Strategy
  • 12.1.4. Medical Exoskeleton: Blue Ocean Strategy and Shift Tools
    • 12.1.4.1. Strategy Canvas
    • 12.1.4.2. Pioneer-Migrator-Settler (PMS) Map
    • 12.1.4.3. Buyer Utility Map

13. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

• 13.1. Chapter Overview
• 13.2. Market Drivers
• 13.3. Market Restraints
• 13.4. Market Opportunities
• 13.5. Market Challenges
• 13.6. Conclusion

14. MEDICAL EXOSKELETON MARKET

• 14.1. Chapter Overview
• 14.2. Forecast Methodology and Key Assumptions
• 14.3. Medical Exoskeleton Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 14.3.1. Scenario Analysis
• 14.4. Key Market Segmentations
• 14.5. Dynamic Dashboard

15. EXOSKELETON MARKET, BY BODY PART COVERED

• 15.1. Chapter Overview
• 15.2. Forecast Methodology and Key Assumptions
• 15.3. Medical Upper Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 15.4. Medical Lower Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 15.5. Medical Full Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 15.6. Data Triangulation and Validation

16. EXOSKELETON MARKET, BY MODE OF OPERATION

• 16.1. Chapter Overview
• 16.2. Forecast Methodology and Key Assumptions
• 16.3. Medical Powered Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 16.4. Medical Passive Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 16.5. Medical Hybrid Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 16.6. Data Triangulation and Validation

17. EXOSKELETON MARKET, BY THEIR FORM

• 17.1. Chapter Overview
• 17.2. Forecast Methodology and Key Assumptions
• 17.3. Medical Rigid Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 17.4. Medical Soft Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 17.5. Data Triangulation and Validation

18. EXOSKELETON MARKET, BY THEIR MOBILITY

• 18.1. Chapter Overview
• 18.2. Forecast Methodology and Key Assumptions
• 18.3. Medical Fixed/ Supported Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 18.4. Medical Mobile / Overground Walking Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 18.5. Data Triangulation and Validation

19. EXOSKELETON MARKET, BY END USERS

• 19.1. Chapter Overview
• 19.2. Forecast Methodology and Key Assumptions
• 19.3. Medical Exoskeleton by Patients: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 19.4. Medical Exoskeleton by Healthcare Providers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 19.5. Data Triangulation and Validation

20. EXOSKELETON MARKET, BY GEOGRAPHY

• 20.1. Chapter Overview
• 20.2. Forecast Methodology and Key Assumptions
• 20.3. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 20.4. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 20.5. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 20.6. Rest of the World: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
• 20.7. Data Triangulation and Validation

21. CONCLUSION

22. EXECUTIVE INSIGHTS

• 22.1. Chapter Overview
• 22.2. Spain-based Small Company
  • 22.2.1. Company Snapshot
  • 22.2.2. Interview Transcript: Co-Founder and Chief Executive Officer
• 22.3. Japan-based Small Company
  • 22.3.1. Company Snapshot
  • 22.3.2. Interview Transcript: Director of Business Planning and Development
• 22.4. US-based Small Company
  • 22.4.1. Company Snapshot
  • 22.4.2. Interview Transcript: Vice President of Sales and Marketing
• 22.5. Canada-based Small Company
  • 22.5.1. Company Snapshot
  • 22.5.2. Interview Transcript: Marketing and Design Manager
• 22.6. India-based Small Company
  • 22.6.1. Company Snapshot
  • 22.6.2. Interview Transcript: Founder and Director

23. APPENDIX 1: BLUE OCEAN STRATEGY AND SHIFT TOOLS

24. APPENDIX 2: TABULATED DATA

25. APPENDIX 3: LIST OF COMPANIES AND ORGANIZATION